Clinical Trials Browser

Phase NA × Immune-related Adverse Event × Clear all

NCT06702566 2024-11-25

The Effect of Serum Ferritin in irAE

Phase NA Recruiting

Other hematologic neoplasmOther solid neoplasm

Immune-related Adverse Event